During 15-17 September, RaySearch will exhibit its latest advances in oncology software at the American Society for Radiation Oncology (ASTRO) 2019 annual meeting in Chicago, USA. On show will be new development in machine learning technology and automation in the RayStation* treatment planning system and the RayCare * oncology information system. Machine learning capabilities were added already in RayStation 8B and are being continuously improved. RaySearch has now been granted FDA 510(k) clearance for deep learning organ segmentation and for machine learning automated planning for a key model. Several planning models are being validated for future FDA 510(k) clearance.
Sep-12-2019, 12:26:28 GMT